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Background: Granulomatosis with polyangiitis, also known as Wegener’s granulomatosis, is a chronic systemic
inflammatory disease that can also involve the eyes. We report a case of massive retinal and preretinal hemorrhages
with perivascular changes as the initial signs in granulomatosis with polyangiitis (Wegener’s granulomatosis).
Case presentation: A 39-year-old Caucasian male presented with blurred vision in his right eye, myalgia and
arthralgia, recurrent nose bleeds and anosmia. Fundus image of his right eye showed massive retinal hemorrhages
and vasculitis-like angiopathy, although no fluorescein extravasation was present in fluorescein angiography.
Laboratory investigations revealed an inflammation with increased C-reactive protein, elevated erythrocyte
sedimentation rate and neutrophil count. Tests for antineutrophil cytoplasmic antibodies (ANCA) were positive for
c-ANCA (cytoplasmatic ANCA) and PR3-ANCA (proteinase 3-ANCA). Renal biopsy demonstrated a focal segmental
necrotizing glomerulonephritis. Granulomatosis with polyangiitis (Wegener’s granulomatosis) was diagnosed and a
combined systemic therapy of cyclophosphamide and corticosteroids was initiated. During 3 months of follow-up,
complete resorption of retinal hemorrhages was seen and general complaints as well as visual acuity improved
during therapy.
Conclusion: Vasculitis-like retinal changes can occur in Wegener’s granulomatosis. Despite massive retinal and
preretinal hemorrhages that cause visual impairment, immunosuppressive therapy can improve ocular symptoms.
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Granulomatosis with polyangiitis (Wegener’s granulo-
matosis) is a chronic systemic inflammatory disease. The
pathophysiological correlate of the disease is a small-
vessel vasculitis with necrotizing granulomatous lesions
of the upper and lower respiratory tract, the kidneys and
other organs. Clinical signs and symptoms are non-
specific and can therefore resemble other vasculitic dis-
orders that affect small- and medium-sized vessels.
Ophthalmic manifestations occur in up to 60% of pa-
tients and may be the initial clinical signs. Wegener’s
granulomatosis can affect any part of the eye and may
cause conjunctivitis, episcleritis and scleritis, keratitis,
uveitis, retinal vasculitis, and involvement of the orbit,
eyelid and nasolacrimal drainage system [1-3].* Correspondence: j.matlach@augenklinik.uni-wuerzburg.de
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massive retinal hemorrhages as the initial presenting
sign which resolved with immunosuppressive therapy.Case presentation
A 39-year-old Caucasian male presented with decreased
visual acuity of 20/400 in his right eye since the day be-
fore. Slit lamp biomicroscopy of the anterior segment
OD confirmed a slightly injected conjunctiva. Fundus
examination of his right eye showed multiple retinal and
preretinal hemorrhages, dilatation of retinal veins and
perivascular changes (Figure 1). Fluorescein angiography
revealed engorgement of retinal veins and staining of the
vessel wall without fluorescein extravasation in the late
phases (Figure 2a, b).
Furthermore, he complained of having conjunctivitis
in his left eye for 6 weeks. Visual acuity in his left eye
was 20/20. Slit lamp biomicroscopy of the anteriorl Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Figure 1 Right eye fundus image at first presentation. Dilatation
of retinal veins, retinal and preretinal retrohyaloidal hemorrhages
and segmental perivascular changes.
Figure 2 Fluorescein angiography of the right eye at first
presentation. Blocked fluorescence as a result of massive retinal
hemorrhages, engorgement of retinal veins with staining of the
vessel wall (a, arteriovenous phase, 0:21 min.). No fluorescein
extravasation in the late phase. Fluorescein leakage of the optic disc
due to ischemia (b, 4:13 min).
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fundus examination was unremarkable.
At that time, he reported a 4-month history of gener-
alized steroid-responsive myalgias and finger joint pain
and a 4-year history of chronic sinusitis and frequent
nose bleeds.
Routine laboratory investigations and special labora-
tory studies for infectious and autoimmune diseases, as
well as otolaryngologic and internistic examination were
performed.
Laboratory diagnostics
Routine laboratory testing revealed an increase in neu-
trophil count of 8.10 x 109/L (normal range 1.8-7.2 ×
109/L), an elevated erythrocyte sedimentation rate (ESR)
of 41 mm in the first hour (normal range 0–15 mm/
hour) and a C-reactive protein (CRP) of 76.5 mg/L (nor-
mal range 0–5 mg/L). Urinary tests and microscopic
examination showed hematuria with dysmorphic eryth-
rocytes (red blood cells 44/μL; normal range 25/μL) and
proteinuria (albumin 434 mg/L; normal range 30 mg/L).
Serological testing excluded recent infectious diseases.
Additional tests for antineutrophil cytoplasmic anti-
bodies (ANCA) were performed and showed a positive
c-ANCA (cytoplasmatic ANCA) titer of 1:640 (negative <
1:40) and a proteinase 3-ANCA (PR3-ANCA) value of >
100 IU/mL (normal 3.5 IU/mL). Anti-myeloperoxidaseantibodies (MPO-ANCA) were within the normal range
(< 9 IU/ml).Otolaryngologic examination
Erosive changes and irregular mucosal thickening were
present in the nasal turbinates. Biopsy of mucosa was
nonspecific. Loss of mucosa had caused dryness, crusting,
epistaxis and anosmia. Computed tomography of the
paranasal sinuses showed irregular mucosal thickening,
but no destruction of the nasal septum or sinus walls.Renal biopsy findings
On histopathological examination, the renal biopsy demon-
strated a focal segmental necrotizing glomerulonephritis.
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According to the American College of Rheumatology
(ACR) criteria, granulomatosis with polyangiitis (Wegener’s
granulomatosis) was diagnosed [4]. The patient received
intravenous corticosteroids (250 mg prednisolone per day
for 3 days tapering over weeks; maintenance dose: 7.5 mg)
and cyclophosphamide 750 mg/m2 (accumulated dose:
11110 mg) for 7 pulses. A good response with remission
of symptoms and reduced c-ANCA and PR3-ANCA
values was noted. After cyclophosphamide and corticoste-
roids had induced remission, subcutaneous methotrexate
(25 mg) was given once weekly to maintain remission.
The renal function, initially slightly impaired (GFR 72 ml/
min/m2) was normalized. The proteinuria improved from
a maximum of 2210 mg/l (albumin/creatinine [a/c] ratio
1177 mg/g) to currently 351 mg/l a/c 238 mg/g.
Complete resorption of central retinal hemorrhages
was seen 3 months after initial presentation and visual
acuity improved to 20/20 in his right eye (Figure 3).
There was no evidence of afferent pupillary defect or
optic nerve atrophy.Figure 3 Right eye fundus image 3 months after initial
presentation. Complete resorption of central retinal hemorrhages
and remnants of vitreous hemorrhage inferiorly.Discussion
Granulomatosis with polyangiitis (Wegener’s granulo-
matosis) is a systemic inflammatory disease characterized
by granulomatous vasculitis that frequently involves the
upper respiratory tract, lungs, kidneys and eyes. Retinal
vasculitis with retinal artery or vein occlusion, chorio-
retinitis, macular edema, exudative retinal detachment
and serious retinal necrosis are rare complications and are
usually associated with poor visual prognosis [2,5-7].
We found clinical signs of a vasculitis-like retinal
angiopathy without fluorescein extravasation in angiog-
raphy. This is in line with case reports of retinal vein oc-
clusion in Wegener’s granulomatosis without clinical
and angiographic signs of vasculitis [5-7]. Contrary to
those reports, the perivascular tissue of retinal veins was
considerably affected in our case.
A combined regime of corticosteroids and cyclophos-
phamide has been demonstrated to achieve remission in
the majority of patients and is recommended for patients
with a more severe form. Surgical interventions to re-
move retinal and preretinal hemorrhages should be lim-
ited to those patients who do not respond to medical
therapy. In our case, even massive retinal and preretinal
hemorrhages resolved within 3 months without surgery.Conclusion
This case report demonstrates that massive retinal and
preretinal hemorrhages in Wegener’s granulomatosis can
resolve under immunosuppressive therapy. Despite the
lack of acute signs of vasculitis, particularly fluorescein
extravasation in angiography, severe vasculitis-like retinalchanges can occur leading to diagnosis of Wegener’s
granulomatosis.
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